Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Cash Flows (Unaudited)

v3.21.2
Condensed Consolidated Statement of Cash Flows (Unaudited)
 9 Months Ended
Sep. 30, 2021
USD ($)
Statement of Cash Flows [Abstract]  
Net loss $ (4,168,087)
Adjustments to reconcile net loss to net cash used in operating activities:  
Interest earned on marketable securities held in Trust Account (42,687)
Unrealized loss on marketable securities held in Trust Account 122
Transactions costs attributed to warrants liabilities 299,770
Change in fair value of the Warrant Liabilities (425,349)
Prepaid expenses and other current asset (525,677)
Accounts payable and accrued expenses 3,230,476
Net cash used in operating activities (1,631,432)
Cash Flows from Investing Activities:  
Investment of cash in Trust Account (253,000,000)
Net cash used in investing activities (253,000,000)
Cash Flows from Financing Activities:  
Proceeds from sale of Units, net of issuance costs 247,940,000
Proceeds from sale of Private Placement Warrants 7,060,000
Proceeds from promissory note – related party 70,000
Repayment of promissory note - related party (75,000)
Payment of offering costs (179,561)
Net cash provided by financing activities 254,815,439
Net Change in Cash and cash equivalents 184,007
Cash and cash equivalents – Beginning
Cash and cash equivalents– Ending 184,007
Non-Cash Investing and Financing Activities:  
Offering costs included in accrued offering costs 318,589
Initial classification of Class A ordinary shares subject to possible redemption 253,000,000
Deferred underwriting fee payable $ 8,855,000